- Report
- April 2025
- 50 Pages
Global
From €2409EUR$2,650USD£2,062GBP
- Report
- October 2024
- 187 Pages
Global
From €3222EUR$3,545USD£2,759GBP
€3580EUR$3,939USD£3,066GBP
- Book
- July 2023
- 1568 Pages
Medetomidine is a drug used in animal pharmaceuticals as a sedative and analgesic. It is an alpha-2 agonist, meaning it binds to alpha-2 receptors in the body to produce a sedative effect. It is commonly used in veterinary medicine to sedate animals for medical procedures, such as surgery, imaging, and endoscopy. It is also used to treat pain and anxiety in animals. Medetomidine is available in injectable and oral forms, and is often used in combination with other drugs, such as opioids, to provide a more comprehensive sedative effect.
Medetomidine is used in a variety of animal species, including cats, dogs, horses, and birds. It is generally considered safe and effective when used as directed. However, it can cause side effects, such as respiratory depression, bradycardia, and hypotension.
The medetomidine market is highly competitive, with a number of companies offering products for animal pharmaceuticals. Some of the major players in the market include Zoetis, Merck Animal Health, Elanco, Bayer Animal Health, and Boehringer Ingelheim. Show Less Read more